These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24638953)

  • 1. Dermatomyositis as a complication of interferon-α therapy: a case report and review of the literature.
    Shiba H; Takeuchi T; Isoda K; Kokunai Y; Wada Y; Makino S; Hanafusa T
    Rheumatol Int; 2014 Sep; 34(9):1319-22. PubMed ID: 24638953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythema Annulare Centrifugum in the Era of Triple Therapy With Boceprevir Plus Pegylated Interferon α-2b and Ribavirin for Hepatitis C Virus Infection.
    di Meo N; Stinco G; Fadel M; Errichetti E; Trevisan G
    J Cutan Med Surg; 2015; 19(3):203-4. PubMed ID: 26060126
    [No Abstract]   [Full Text] [Related]  

  • 3. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
    Quinn D; Kuchler E; Deming P; Arora S
    Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-PL7 antisynthetase syndrome under interferon therapy.
    Aouba A; Georgin-Lavialle S; Terrier B; Guillevin L; Authier FJ
    Joint Bone Spine; 2011 Jan; 78(1):94-7. PubMed ID: 20851661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b.
    Venezia G; Licata A; Di Marco V; Craxì A; Almasio PL
    Dig Liver Dis; 2005 Nov; 37(11):882-5. PubMed ID: 16169301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major depressive episode with psychotic features induced by pegylated interferon-alpha-2b and ribavirin treatment.
    Sockalingam S; Balderson K
    Int Clin Psychopharmacol; 2005 Sep; 20(5):289-90. PubMed ID: 16096520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C.
    Farshidi D; Chiu MW
    J Am Acad Dermatol; 2010 Jan; 62(1):164-165. PubMed ID: 20082904
    [No Abstract]   [Full Text] [Related]  

  • 8. Retinal thrombosis secondary to the combination therapy of pegylated interferon and ribavirin for chronic hepatitis C virus infection. A rare complication.
    Ortega-Ibarra FS; Remes-Troche JM
    Rev Esp Enferm Dig; 2013; 105(5):291-2. PubMed ID: 23971660
    [No Abstract]   [Full Text] [Related]  

  • 9. A rare complication of pegylated interferon Alfa 2a in a hepatitis C-positive patient on maintenance hemodialysis.
    Satish R; ; Mathew T
    Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):139-42. PubMed ID: 22237239
    [No Abstract]   [Full Text] [Related]  

  • 10. Pegylated interferon induced interstitial pneumonitis in a patient with hepatitis C infection.
    Torres-Macho J; Jara-Chinarro B; Suárez-Aliaga B; Gámez-Díez S; García-de-Casasola G; de-Cuenca-Morón B
    Rev Esp Enferm Dig; 2010 Oct; 102(10):606-8. PubMed ID: 21039072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C.
    Golstein PE; Delforge ML; Deviere J; Marcellin P
    J Viral Hepat; 2004 Mar; 11(2):183-6. PubMed ID: 14996354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS.
    Abi-Nassif S; Mark EJ; Fogel RB; Hallisey RK
    Chest; 2003 Jul; 124(1):406-10. PubMed ID: 12853555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult respiratory distress syndrome after treatment with pegylated interferon alpha-2a and ribavirin.
    Vartany E; Caldwell CA; Trow TK
    Heart Lung; 2008; 37(2):153-6. PubMed ID: 18371508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
    Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
    Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe interstitial pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis C infection.
    Fuhrmann V; Kramer L; Bauer E; Laferl H; Tucek G; Dekan G; Schenk P
    Dig Dis Sci; 2004; 49(11-12):1966-70. PubMed ID: 15628735
    [No Abstract]   [Full Text] [Related]  

  • 16. Cryptosporidiosis in a patient on PEG-interferon and ribavirin for recurrent hepatitis C after living donor liver transplantation.
    Manz M; Steuerwald M
    Transpl Infect Dis; 2007 Mar; 9(1):60-1. PubMed ID: 17313476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic colitis during interferon-ribavirin therapy for chronic hepatitis C: a case report.
    Baik SJ; Kim TH; Yoo K; Moon IH; Cho MS
    World J Gastroenterol; 2012 Aug; 18(31):4233-6. PubMed ID: 22919260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyolysis associated with the co-administration of daptomycin and pegylated interferon α-2b and ribavirin in a patient with hepatitis C.
    Colomba C; Rubino R; Siracusa L; Mazzola G; Titone L
    J Antimicrob Chemother; 2012 Jan; 67(1):249-50. PubMed ID: 21965434
    [No Abstract]   [Full Text] [Related]  

  • 19. Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation.
    Kontorinis N; Agarwal K; Elhajj N; Fiel MI; Schiano TD
    Liver Transpl; 2006 May; 12(5):827-30. PubMed ID: 16628699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect and safety of the treatment of recurrent hepatitis C infection after orthotopic liver transplantation with pegylated interferon α2b and ribavirin.
    Perrakis A; Yedibela S; Schuhmann S; Croner R; Schellerer V; Demir R; Hohenberger W; Müller V
    Transplant Proc; 2011 Dec; 43(10):3824-8. PubMed ID: 22172854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.